Risk of Hepatic Dysfunction with Methotrexate in Pediatric Inflammatory Diseases: A Self-Controlled Study Using the P-MICS
Information
Society, Date, Venue：
The 11th Annual Meeting of Japanese Society of Drug Safety, August 2-3, 2025, Nagoya
Title：
Risk of Hepatic Dysfunction with Methotrexate in Pediatric Inflammatory Diseases: A Self-Controlled Study Using the
P-MICS
Speakers：
Masayoshi Nakakuni1)2)3)、Azusa Hara3)、Kosuke Nakano1)、Seiji Mitsui1)、Naoko Deguchi1)、Seiko Miyazaki1)3)4)
Institution：
1) Network Promotion Unit, Department of Multicenter Collaboration, Clinical Research Center, National Center for
Child Health and Development
2) Gene & Cell Therapy Promotion Center, National Center for Child Health and Development
3) Division of Social Pharmacy and Regulatory Science, Showa Pharmaceutical University
4) Pharmacoepidemiology Unit, Center for Social and Pharmacy Education and Research, Teikyo Heisei University School
of Pharmacy